''Marinol'' (a brand formulation of dronabinol)<ref>{{Cite web|url=http://www.drugscience.org/Archive/bcr3/n3_Marinol.html|title=The Bulletin of Cannabis Reform|website=www.drugscience.org|access-date=2017-02-17}}</ref> is a schedule III controlled substance, approved for relief of nausea and vomiting in persons undergoing cancer chemotherapy and to improve appetite in persons with AIDS. It is dispensed in gelatin capsules containing synthetic Δ-9-Tetrahydrocannabinol dissolved in sesame oil. Liberals advocating "medicinal" marijuana do their best to ignore this drug. A 1998 survey of physicians, addiction specialists and police demonstrated no evidence or concern about the abuse, dependence or diversion of Marinol.<ref>{{Cite journal|last=Calhoun|first=S. R.|last2=Galloway|first2=G. P.|last3=Smith|first3=D. E.|date=1998-04-01|title=Abuse potential of dronabinol (Marinol)|url=https://www.ncbi.nlm.nih.gov/pubmed/?term=9692381|journal=Journal of Psychoactive Drugs|volume=30|issue=2|pages=187–196|doi=10.1080/02791072.1998.10399689|issn=0279-1072|pmid=9692381}}</ref> About this time, the DEA moved the drug from schedule II to the less restrictive schedule III.<ref>{{Cite web|url=https://www.deadiversion.usdoj.gov/fed_regs/rules/1998/fr1105.htm|title=Proposed Rules - 1998 - Schedules of Controlled Substances: Rescheduling of Synthetic Dronabinol (Martinol®; (-)-Δ9-(trans)-Tetrahydrocannabinol in Sesame oil and Encapsulated in Soft Gelatin Capsules) From Schedule II to Schedule III.|website=www.deadiversion.usdoj.gov|language=en-US|access-date=2017-02-17}}</ref> | ''Marinol'' (a brand formulation of dronabinol)<ref>{{Cite web|url=http://www.drugscience.org/Archive/bcr3/n3_Marinol.html|title=The Bulletin of Cannabis Reform|website=www.drugscience.org|access-date=2017-02-17}}</ref> is a schedule III controlled substance, approved for relief of nausea and vomiting in persons undergoing cancer chemotherapy and to improve appetite in persons with AIDS. It is dispensed in gelatin capsules containing synthetic Δ-9-Tetrahydrocannabinol dissolved in sesame oil. Liberals advocating "medicinal" marijuana do their best to ignore this drug. A 1998 survey of physicians, addiction specialists and police demonstrated no evidence or concern about the abuse, dependence or diversion of Marinol.<ref>{{Cite journal|last=Calhoun|first=S. R.|last2=Galloway|first2=G. P.|last3=Smith|first3=D. E.|date=1998-04-01|title=Abuse potential of dronabinol (Marinol)|url=https://www.ncbi.nlm.nih.gov/pubmed/?term=9692381|journal=Journal of Psychoactive Drugs|volume=30|issue=2|pages=187–196|doi=10.1080/02791072.1998.10399689|issn=0279-1072|pmid=9692381}}</ref> About this time, the DEA moved the drug from schedule II to the less restrictive schedule III.<ref>{{Cite web|url=https://www.deadiversion.usdoj.gov/fed_regs/rules/1998/fr1105.htm|title=Proposed Rules - 1998 - Schedules of Controlled Substances: Rescheduling of Synthetic Dronabinol (Martinol®; (-)-Δ9-(trans)-Tetrahydrocannabinol in Sesame oil and Encapsulated in Soft Gelatin Capsules) From Schedule II to Schedule III.|website=www.deadiversion.usdoj.gov|language=en-US|access-date=2017-02-17}}</ref> |